| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000016192 |
| Receipt No. | R000018778 |
| Official scientific title of the study | Investigation for the effect of duloxetine on adolescent depression; Ver. 2 |
| Date of disclosure of the study information | 2015/03/01 |
| Last modified on | 2017/06/30 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Investigation for the effect of duloxetine on adolescent depression; Ver. 2 | |
| Title of the study (Brief title) | E-DAD | |
| Region |
|
|
| Condition | ||
| Condition | Major Depressive Disorder | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the efficacy of duloxetine on adolescent depression with QOL as an index. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Quolity of Life; SF-36v2
|
| Key secondary outcomes | Depression; BDI-II
Anxiety; STAI Autistic Tnedency; PARS-TR Attention Deficit and/or Hyperactivity; ADHD-RS |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is considered as a block. |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | * On;y cognitive behavioral therapy of 50 minutes.
* 1W, 4W, 6W, 8W total 4 times. |
|
| Interventions/Control_2 | * Cognitive behavioral therapy of 50 min. and duloxetine.
* CBT; 1W, 4W, 6W, 8W total 4 times. * Duloxetine; At first we will prescribe 20mg. 1 week later we will increase to 40mg. 3 week later, depending on the request of subjects, we will regulate quantity of prescription from 20mg to 60mg. We will not change of prescription for 4 weeks. |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patients of Major Depressive Disorder diagnosed by both of DSM-IV-TR and DSM-5. | |||
| Key exclusion criteria | * Remitted or partial remitted patients
* Patients with sever inhibition so as not to tolerate CBT, questionnaire and structured interview * Pregnant women * Patients with physical disorder |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Takahiko Inagaki |
| Organization | Shiga University of Medical Science |
| Division name | Department of Community Psychiatric Medicine |
| Address | Seta Tsukinowa-cho, Otsu City, Shiga |
| TEL | 077-548-2291 |
| kerosuke@belle.shiga-med.ac.jp | |
| Public contact | |
| Name of contact person | Takahiko Inagaki |
| Organization | Shiga University of Medical Science |
| Division name | Department of Community Psychiatric Medicine |
| Address | Seta Tsukinowa-cho, Otsu City, Shiga |
| TEL | 077-548-2291 |
| Homepage URL | http://com-psy.jp/ |
| kerosuke@belle.shiga-med.ac.jp | |
| Sponsor | |
| Institute | Shiga University of Medical Science |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Shionogi & Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | Japanese Red Cross Society Nagahama Hospital |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 滋賀医科大学医学部附属病院(滋賀県)、長浜赤十字病院(滋賀県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | discontinued |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018778 |